From the Research
DMSO (Dimethyl Sulfoxide) is not recommended as a primary treatment for arthritis management due to limited scientific evidence supporting its effectiveness and potential side effects.
Overview of DMSO for Arthritis
DMSO has been studied for its potential use in arthritis management, but the current evidence does not strongly support its use as a primary treatment. While some people report temporary pain relief when DMSO is applied topically to arthritic joints, clinical research does not demonstrate significant benefits in reducing inflammation or slowing disease progression 1, 2.
Efficacy and Safety of DMSO
A systematic review of randomized controlled trials found that DMSO may provide some pain relief, but the evidence is not conclusive, and methodological issues were identified in many of the studies 1. Another study found that topical diclofenac containing DMSO was effective in relieving pain and improving physical function in patients with knee osteoarthritis, but the efficacy of DMSO itself was not established 2.
Comparison to Conventional Treatments
Conventional treatments like NSAIDs, physical therapy, and disease-modifying drugs have much stronger evidence for arthritis management 3, 4. These treatments have been shown to reduce inflammation, slow disease progression, and improve quality of life for patients with arthritis.
Potential Risks and Side Effects
DMSO can cause side effects, including skin irritation, garlic-like breath odor, and may interact with other medications by enhancing their absorption 5, 2. Additionally, DMSO may mask symptoms while potentially allowing joint damage to progress, which could lead to delayed diagnosis and treatment of underlying conditions.
Recommendation
Given the limited evidence and potential risks, DMSO is not recommended as a primary treatment for arthritis management. Patients considering DMSO should consult with their healthcare provider first, as self-treatment could delay more effective interventions. Conventional treatments with stronger evidence should be prioritized, and patients should be closely monitored for potential side effects and disease progression.